Compound 21, the first orally active, selective agonist of the angiotensin type 2 receptor (AT2): implications for AT2 receptor research and therapeutic potential

Compound 21, the first orally active, selective agonist of the angiotensin type 2 receptor (AT2): implications for AT2 receptor research and therapeutic potential

Bibliographic Details
Main Authors: Thomas Unger, Björn Dahlöf
Format: Article
Language:English
Published: Hindawi - SAGE Publishing 2010-03-01
Series:Journal of the Renin-Angiotensin-Aldosterone System
Online Access:https://doi.org/10.1177/1470320309347792

Internet

https://doi.org/10.1177/1470320309347792

Similar Items